Nakaichi, Tetsu
Nakamura, Satoshi
Ito, Kimiteru
Takahashi, Kana
Takemori, Mihiro
Kashihara, Tairo
Kunito, Kouji
Murakami, Naoya
Iijima, Kotaro
Chiba, Takahito
Nakayama, Hiroki
Mikasa, Shohei
Nishio, Teiji
Okamoto, Hiroyuki
Itami, Jun
Kurihara, Hiroaki
Igaki, Hiroshi
Article History
Received: 17 May 2022
Accepted: 2 December 2022
First Online: 19 December 2022
Declarations
:
: There is no ethical problem or conflict of interest regarding this manuscript. This study was approved by the institutional review board of national cancer center hospital, Tokyo, Japan (approval number, 2017-091), and all the participants agreed with informed consent.
: Not applicable.
: This study was supported by research funds from Cancer Intelligence Care Systems, Inc. (Satoshi Nakamura). This study was also supported by commissioned study from Stella Pharma Corporation and Cancer Intelligence Care Systems, Inc. (Hiroshi Igaki). These sponsors had no roles in the design, execution, interpretation, or writing of this study. All other authors had no conflict of interest to report.